![]() ![]() ![]() The MoCA application for electronic tablets will improve the reliability of testing and retesting. To request permission, please fill out the form below. Written permission and Licensing Agreement is required if funded by commercial entity or pharma. The test should be made available free of charge to patients. MoCA© may be used, reproduced, and distributed WITHOUT permission. Universities/Foundations/Health Professionals/Hospitals/Clinics/Public Health Institutes: The site is full of useful information on the use of the test including a good FAQ page that includes tips on administration, scoring, and interpretation.Ĭlinical use of the test ( Permissions) is free for the following: The MoCA has been found to be useful to detect mild cognitive impairment in many conditions including Alzheimer’s disease, Vascular Cognitive Impairment, Parkinson’s disease, Lewy Body, Fronto-temporal dementia, Multiple Sclerosis, Huntington disease, Brain Tumors, ALS, Sleep Apnea, Heart Failure, Substance abuse, Schizophrenia, HIV, and Head Trauma. Several neurological and systemic diseases are accompanied by cognitive impairment. The test, Version 8.1, was created, which replaces version 7.1. Following the addition of the Memory Index Score to the MoCA test, a new version of This score will help clinicians monitor more closely high risk patients, and researchers select subjects that are more likely to benefit from therapeutic interventions. The MIS score helps determine which patient with Mild Cognitive Impairment is most likely to convert to Dementia over an average follow-up of 18 months. ![]() This score was created in 2010 and validated in a study in 2013 (Julayanont P, et al. The Memory Index Score (MoCA-MIS), consists of scoring the memory cueing section which was only assessed qualitatively. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. In 2003, after analysis of the 2000 study results, a few elements of the test were optmized, and a new validation study was completed in 2003-2004, which confirmed the test’s discriminatory ability to distinguish Normal controls, from subjects with Mild Cognitive Impairment or Mild Alzheimer’s disease (Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JLC, Chertkow H. The best place to start learning about the test is the About page : Here is the YouTube video, Montreal Cognitive Assessment (MoCA): Administration and Scoring The home of the Montreal Cognitive Assessment tool is Here is a YouTube video, Montreal Cognitive Assessment (MoCA) Administration, that was given to a patient after he failed the MiniCog on an earlier visit . ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |